A Fast, Efficient Approach to Monitoring Regulatory Compliance
SCAIR’s Regulatory Incident Consolidator will Help you Monitor your Supply Base
To protect patients’ well-being, biopharma companies are amongst the most scrutinised organisations in the world. But even companies with the most mature and sophisticated quality management systems can fall foul of exacting regulatory standards. The resulting enforcement action can cause huge losses in profits and investor confidence.
A critical step in monitoring the compliance status of your supply base is collating non-compliance data from multiple medicines regulators. This can be a complex and time-consuming task.
Let us do the leg work for you with SCAIR’s unique Regulatory Incident Consolidator module. The consolidator quickly and efficiently collates and analyses non-compliance data from major life science industry regulators. This extensive dataset helps enable forensic analysis of specific incidents and prediction of trends – a big part of any due diligence process.
We can also use this data to create qualified risk analysis packages to support your corporate insurance procurement.
Get in touch with us today to find out how we can help your business meet its regulatory standards.
For further information on how SCAIR® can identify specific regulatory incidents, take a look at the regulatory incident monitor tool.